Today@Dal
» Go to news mainClinical Research Trial
Posted by IWK Health Centre on
July 19, 2013
in
General Announcements
Vaccine Study for Males Aged 18-44
RSV is a serious lung infection for infants, young children and the elderly.
The IWK is doing a study on a vaccine that may provide protection against RSV.
If you are a healthy man between the ages of 18 and 44 and interested in taking part in this important study, please contact DARLENE at 470-8931.
If eligible to take part in this study, you will be reimbursed for travel and parking.
Recent News
- In Memoriam ‑ Colin Spinney
- Document delivery during Canada Post strike
- New surplus items added in Halifax
- Dal Tigers birthday parties
- Celebrate culture, creativity, and sustainability at the IEW Fashion Show!
- Student Accessibility Closure Friday, November 22
- Job postings
- Where suppliers can meet Dal Procurement